Budesonide for Asthma and Chronic Obstructive Pulmonary Disease

Basic Information
Place of Origin: China
Brand Name: ChineseHormone
Certification: GMP, ISO 9001, USP
Model Number: CAS 51333-22-3
Minimum Order Quantity: Free samples Available
Price: negotiated
Packaging Details: as your required
Delivery Time: 3-5 working days
Payment Terms: Western Union, MoneyGram, T/T, Bitcoin
Supply Ability: 500-1000 kg / month
MW: 430.534 MF: C25H34O6
Appearance: White Powder Biological Half-life: 2.0-3.6 Hours
Bioavailability: 10-20% (first Pass Effect) Trade Names: Pulmicort, Rhinocort, Other
Email: Tonyraws810@gmail.com Whatsapp: 86-15871352379
Wickr: Tonyraws
High Light:

pharmaceutical raw material


raw pharmaceutical materials


Budesonide Steroid Medication for Asthma and Chronic Obstructive Pulmonary Disease


Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, nasal spray, and rectal forms.The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD).


The nasal spray is used for allergic rhinitis and nasal polyps. The pills in a delayed release form and rectal forms may be used for inflammatory bowel disease including Crohn's disease, ulcerative colitis and microscopic colitis.


Medical uses




Budesonide is nebulized for maintenance and prophylactic treatment of asthma including patients who require oral corticosteroids and those who may benefit from a systemic dose reduction.


Inflammatory bowel disease


Formulations of delayed-release Budesonide can be effective treatment for mild-to-moderately active Crohn's disease involving the ileum and/or ascending colon.A Cochrane review found evidence for up to 3 months (but not longer) of maintenance of remission Crohn's disease.

Budesonide assists in the induction of remission in people with active ulcerative colitis.


Allergic rhinitis


Nasal spray budesonide is a treatment for allergic rhinitis.


Budesonide for Asthma and Chronic Obstructive Pulmonary Disease 0




Budesonide may cause:




Budesonide is contraindicated as a primary treatment of status asthmaticus or other acute episode of asthma where intensive measures are required. It is also contraindicated for patients who have hypersensitivity to budesonide.


Budesonide for Asthma and Chronic Obstructive Pulmonary Disease 1


Mechanism of action



Dietary considerations


Those taking tablets or capsules orally should avoid grapefruit juice and echinacea.

Also, high fat meals delay absorption but do not impede absorption.


Trade names Pulmicort, Rhinocort, other
CAS Number 51333-22-3
Formula C25H34O6
Molar mass 430.534 g/mol
Biological half-life 2.0-3.6 hours
Protein binding 85-90%
Bioavailability 10-20% (first pass effect)



Any needs, please contact me

Email: tonyraws810@gmail.com

Whatsapp: 86-15871352379

Wickr: tonyraws


Contact Details
Sales Manager

Phone Number : +8613657291547

WhatsApp : +https://api.whatsapp.com/send?phone=8615871352379